Rare diseases
Investigational molecules
Locations
Back to Portugal95 clinical trials in Senhora Da Hora, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)PortugalOrelabrutinib in Patients with Primary Progressive Multiple Sclerosis
PortugalZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
PortugalA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
PortugalStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
PortugalStudy of trospium chloride and xanomeline tartrate combination for agitation in Alzheimer's disease patients: Long-term safety evaluation
PortugalStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
PortugalStudy on Lebrikizumab for Adults with Chronic Rhinosinusitis and Nasal Polyps Using Intranasal Corticosteroids
PortugalStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
PortugalA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
PortugalPhase 3 Study of Subcutaneous vs Intravenous Tarlatamab with Siltuximab in Relapsed Extensive-Stage Small Cell Lung Cancer after Platinum Chemotherapy
PortugalEfficacy and safety of lunsekimig in adults with inadequately controlled eosinophilic COPD: a randomized, double‑blind, placebo‑controlled trial
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Alzheimer's disease and associated conditions, including studies on psychosis treatment and cognitive decline prevention. Multiple trials exploring migraine prevention with novel therapeutic approaches.
Studies are evaluating both symptomatic relief and disease modification strategies.
Comprehensive research in breast cancer treatments, particularly focusing on HR+/HER2- variants and innovative combination therapies. Advanced studies in non-small cell lung cancer exploring new treatment paradigms.
Trials emphasize targeted therapies and immunotherapy approaches.
Groundbreaking research in severe asthma management and chronic rhinosinusitis. Studies evaluating new treatments for COPD with focus on long-term safety and efficacy.
Emphasis on innovative inhaler combinations and targeted biological treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
